Study guide
2.2 Chapter 400j, 420b/420c, and RCSA 20-576
Connecticut Multistate Pharmacy Jurisprudence Examination CT MPJE
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 About the Connecticut MPJE 1.2 Application, Fees, ATT, and Pearson VUE 1.3 Blueprint, Scoring, Retakes, and Study Strategy
2 Connecticut Regulatory Structure
2.1 DCP and the Commission of Pharmacy 2.2 Chapter 400j, 420b/420c, and RCSA 20-576 2.3 Federal vs Connecticut Law (More Restrictive Rule)
3 Pharmacist Licensure, Interns, PIC, and CE
3.1 Pharmacist Qualifications and Exam Path 3.2 Interns, Score Transfer, and Reciprocity 3.3 Pharmacist-in-Charge / Pharmacist Manager 3.4 License Renewal and Continuing Education
4 Technicians and Non-Pharmacist Personnel
4.1 Technician Registration and Certification 4.2 Community Technician Ratios (20-576-36) 4.3 Institutional Ratios and Advanced Pharmacy Technicians 4.4 Technician Limitations, Interns, and Unlicensed Staff
5 Discipline, Impairment, and Unlicensed Practice
5.1 Disciplinary Grounds (CGS § 20-579) 5.2 Impaired Practitioner Reporting and Programs 5.3 Unlicensed Practice, Penalties, and Appeals
6 Federal Drug Law Foundations
6.1 FDCA, Adulteration, and Misbranding 6.2 FDA Approval, Recalls, and OTC vs Rx 6.3 DSCSA, HIPAA, OBRA ’90, and PPPA
7 Federal Controlled Substances
7.1 CSA Schedules and Definitions 7.2 DEA Registration and Forms 222, 106, 41 7.3 Federal Controlled-Substance Prescription Rules 7.4 Inventory, Theft, Loss, and Disposal
8 Prescription Issuance in Connecticut
8.1 Who May Prescribe in Connecticut 8.2 Noncontrolled Prescription Form and Content 8.3 Controlled Prescriptions and the EPCS Mandate
9 Refills, Partial Fills, and Opioid Limits
9.1 Refill Authority (Noncontrolled and CIII–V) 9.2 Partial Fills of Schedule II Prescriptions 9.3 Connecticut Opioid Supply Limits (7-day / 5-day)
10 Administration, CDTM, and Standing Orders
10.1 Pharmacist Immunization Authority 10.2 Collaborative Drug Therapy Management 10.3 Naloxone and Opioid Antagonist Access 10.4 Emergency and Hormonal Contraception
11 Counseling, Confidentiality, and Returns
11.1 Counseling and Offer to Counsel 11.2 HIPAA and Connecticut Confidentiality 11.3 Return, Reuse, and Take-Back
12 Corresponding Responsibility and DUR
12.1 Corresponding Responsibility and Legitimate Medical Purpose 12.2 Prospective Drug Utilization Review 12.3 Exceptions and Conditions Prohibiting Dispensing
13 Transfers, Labeling, Packaging, and Delivery
13.1 Transferring Prescriptions 13.2 Labeling of Dispensed Drugs 13.3 Packaging and the Poison Prevention Packaging Act 13.4 Delivery of Drugs
14 CPMRS, Substitution, and Nonprescription Drugs
14.1 CPMRS Query and Reporting 14.2 Generic and Biosimilar Substitution 14.3 CMEA and Behind-the-Counter Products 14.4 OTC Labeling, Hazardous, and Restricted Nonprescription Drugs
15 Ordering, Records, and Inventories
15.1 Ordering and Acquisition (DEA 222/CSOS) 15.2 Distribution and DSCSA Records 15.3 Recordkeeping Content and Three-Year Retention 15.4 Controlled-Substance Inventories and CT Perpetual CII
16 Storage, Security, and Hazardous Drugs
16.1 Controlled-Substance Storage and Security 16.2 Hazardous Drugs (USP <800>, NIOSH) 16.3 Non-Pharmacist Access to Drugs
17 Compounding and Central Fill
17.1 Nonsterile Compounding (USP <795>, RCSA 20-576-69) 17.2 Sterile Compounding (USP <797>, RCSA 20-576-64) 17.3 Central Fill, 503A, and 503B Outsourcing
18 Pharmacy Permits and Practice Settings
18.1 Pharmacy License, Hours, Manager, and Signage 18.2 Nonresident, Hospital, Nuclear, and Automated Dispensing 18.3 Inspection, Closure, and Facility Discipline
2.2 Chapter 400j, 420b/420c, and RCSA 20-576
Key Takeaways Explain This Topic AI
CGS Chapter 400j (Pharmacy Practice Act, § 20-570 et seq.) plus RCSA Title 20, subtitle 20-576, is the starting stack for licenses, PIC/manager, technicians, interns, hours, compounding, CDTM, immunizations, and pharmacy QA.
Chapter 420b (dependency-producing drugs) and Chapter 420c (controlled-substance registration) are the CS statute homes; RCSA 21a-243, 21a-244, 21a-254, and 21a-262 add scheduling, electronic Rx storage, records/CPMRS, and security.
RCSA § 20-576-13 requires a pharmacy to be open at least 35 hours per week, except as otherwise authorized for specified classes of pharmacies; sterile and non-sterile compounding pharmacies have the same 35-hour floor unless the Commission grants a waiver.
DCP's Drug Control Laws and Regulations page is the official index; the Comprehensive Drug Laws PDF is the working compilation, and CGS Chapter 400j is published at the CGA 2025 compilation.
On the MPJE, '20-576' usually means the RCSA practice-of-pharmacy regulations unless the item expressly cites section 20-576 of the general statutes (the regulation-authorizing statute).
Last updated: August 2026
Navigation beats memorizing the entire code
The CT MPJE is not a recitation of every subsection in Title 20 and Title 21a. It is a navigation exam . When a stem describes hours, a technician ratio, an emergency oral CII, or a CPMRS query, you should already know which chapter to open . DCP publishes the map on its Drug Control Laws and Regulations page and binds the working text in the Connecticut Comprehensive Drug Laws PDF (updated May 2025). The General Assembly text of the Pharmacy Practice Act is CGS Chapter 400j (2025 compilation). Regulations live on the eRegulations portal under the RCSA title and subtitle cited below.
Do not dump the code into your short-term memory. Learn the stack , then attach a handful of high-yield hooks (hours, where techs live, where CS records live). Later chapters teach the operational rules; this section teaches where those rules sit .
Statute versus regulation
Connecticut General Statutes (CGS) are what the General Assembly enacted. Regulations of Connecticut State Agencies (RCSA) are how DCP implements those statutes. Under CGS § 20-575 , the commissioner adopts Pharmacy Practice Act regulations with the advice and assistance of the Commission . CGS § 20-576 is the statute titled 'Regulations'—the authorization. RCSA subtitle 20-576 is the large body of practice-of-pharmacy rules (hours, managers, technicians, compounding, intern registration).
That numbering collision is itself a trap. On this exam, a bare citation to 20-576 almost always means the RCSA practice rules unless the item says 'section 20-576 of the general statutes.' The same pairing appears elsewhere: CGS § 20-633 (pharmacist immunizations) sits next to RCSA 20-633 ; CGS § 20-631 (collaborative drug therapy management) next to RCSA 20-631 ; CGS § 20-635 next to RCSA 20-635 quality-assurance programs.
The statute stack a candidate must be able to open
DCP's official index lists these relevant state statutes :
Chapter 400j — Pharmacy (Practice Act, § 20-570 et seq. ): who is a pharmacist, intern, and technician; pharmacy licenses; pharmacist manager; discipline ( § 20-579 ); CE ( § 20-600 ); substitution ( § 20-619 ); CDTM, immunizations, and related practice authorities
Chapter 417 — Pure Food and Drug Act and Chapter 418 — Uniform Food, Drug and Cosmetic Act : article-level food/drug adulteration and misbranding analogs
Chapter 419 — Retail Drug Control Act : retail-level drug control rules, distinct from the Practice Act
Chapter 420b — Dependency-Producing Drugs : controlled-substance prescriptions and dispensing , including § 21a-249 (form, EPCS, emergency oral CII) and § 21a-250 (pharmacist's rights and duties, three-year prescription file)
Chapter 420c — Controlled Substance Registration : who must hold a Connecticut CS registration in addition to DEA registration
Cannabis has its own homes ( Chapter 420f medical marijuana; Chapter 420h adult-use). Do not import those program rules into a 400j pharmacy-practice item unless the stem is actually about a cannabis credential.
The regulation stack
DCP's same page lists the RCSA titles you will actually use in a community or institutional pharmacy:
- RCSA 20-576 — practice of pharmacy (the workhorse subtitle)
- RCSA 20-633 — administration of vaccine by pharmacists
- RCSA 20-631 — collaborative drug therapy management
- RCSA 20-635 — quality assurance programs for pharmacies
- RCSA 21a-243 — designation of controlled substances (Connecticut's schedule list)
- RCSA 21a-244 — storage and retrieval of prescription information for controlled substances
- RCSA 21a-254 — recordkeeping for controlled drugs, including CPMRS reporting duties
- RCSA 21a-262 — minimum security and safeguards for storage and handling of controlled substances
Inside RCSA 20-576 , know the hooks , not every line: intern registration ( 20-576-8 ); pharmacy hours of operation ( 20-576-13 ); security during a momentary pharmacist absence ( 20-576-14 ); pharmacist manager; community and institutional technician ratios and technician limitations; sterile compounding ( 20-576-64 to 20-576-68 ) and non-sterile compounding ( 20-576-69 to 20-576-73 ). Ratio arithmetic and compounding USP overlays belong in later chapters. This chapter's job is: if the stem is about techs or hours or compounding, start in RCSA 20-576 , not in Chapter 420c.
If the question is about X, start in Y
- If the question is about… Open first
- Pharmacist/pharmacy/intern/technician credentials, PIC/manager, discipline, CE, substitution CGS Chapter 400j
- Hours, tech ratios, intern registration, compounding, prescription-department security RCSA 20-576
- Immunizations by pharmacists CGS/RCSA 20-633
- Collaborative drug therapy management CGS/RCSA 20-631
- Pharmacy quality-assurance programs CGS/RCSA 20-635
- Adulteration, misbranding, food-drug articles Chapters 417 and 418
- Retail drug-control (non-practice-act retail rules) Chapter 419
CS prescription form, EPCS, emergency oral CII, who may dispense CS Chapter 420b (especially §§ 21a-249, 21a-250)
- Who must hold a Connecticut CS registration Chapter 420c
- Which substances Connecticut schedules, and how RCSA 21a-243
- Electronic storage/retrieval of CS prescription information RCSA 21a-244
- CS records and CPMRS CGS/RCSA 21a-254
- CS cages, safes, and physical security RCSA 21a-262
- High-yield hook: 35 hours per week
RCSA § 20-576-13 states that a pharmacy shall be open at least thirty-five hours per week , except as otherwise authorized in regulations concerning classes of pharmacies adopted under CGS § 20-576(a)(2) . Related rules keep the prescription department on the same floor: after an after-hours arrangement is approved, the prescription department still must be open to provide pharmaceutical services not less than 35 hours per week . Sterile compounding pharmacies ( RCSA § 20-576-68 ) and non-sterile compounding pharmacies ( RCSA § 20-576-73 ) share the 35-hour floor unless the Commission grants a waiver under the compounding-waiver regulation.
A pandemic executive-order waiver that once allowed shorter hours is not current law. Unless an item is clearly historical, teach 35 hours/week as the default. A 28-hour community pharmacy without a class-based or Commission waiver fails 20-576-13 .
How to work a stem
Use a three-question filter before you pick an answer:
Is this about people, permits, hours, compounding, or clinical pharmacy services ? Start in 400j + RCSA 20-576 (and 20-631 / 20-633 / 20-635 if tagged).
Is this about a controlled substance as a prescription, record, schedule, registration, or vault? Start in 420b / 420c and the 21a-243 / 244 / 254 / 262 regulations.
Is this about the article (adulteration, misbranding, retail sale of a drug as a product)? Start in 417 / 418 / 419 , then overlay federal FDCA if the stem mentions FDA.
Then ask whether a federal floor also applies (DEA, FDA, HIPAA). Section 2.3 is the conflict rule. Official starting URLs: DCP laws index at portal.ct.gov (Drug Control / Laws and Regs) and the CGA 2025 Chapter 400j compilation. Keep the Comprehensive Drug Laws PDF on the device you use to study so you are not guessing chapter numbers under time pressure.